🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 3 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/10/2021 66,25 66,43 64,47 64,49 -2,42% 2,96% 268.500
26/10/2021 66,43 67,28 65,32 66,09 +0,36% 2,95% 512.900
25/10/2021 65,78 66,84 65,03 65,85 -0,27% 2,75% 492.600
22/10/2021 66,91 66,91 64,90 66,03 -1,29% 3,00% 396.100
21/10/2021 66,90 67,70 66,65 66,89 +0,21% 1,58% 229.500
20/10/2021 66,81 67,04 65,58 66,75 -0,48% 2,19% 289.300
19/10/2021 66,73 67,61 66,18 67,07 +1,41% 2,14% 272.200
18/10/2021 65,92 66,41 65,38 66,14 -0,03% 1,56% 305.000
15/10/2021 67,83 67,94 65,41 66,16 -1,00% 3,73% 559.900
14/10/2021 63,99 66,92 63,91 66,83 +5,46% 4,71% 540.100
13/10/2021 63,40 64,50 62,36 63,37 +0,16% 3,38% 369.400
12/10/2021 60,48 63,44 59,77 63,27 +5,27% 6,07% 533.300
11/10/2021 59,83 60,91 59,12 60,10 -0,38% 2,99% 347.900
08/10/2021 59,23 60,60 58,74 60,33 +2,29% 3,15% 708.800
07/10/2021 58,50 60,50 58,32 58,98 +1,53% 3,73% 454.400
06/10/2021 59,41 60,32 57,94 58,09 -3,26% 4,01% 603.100
05/10/2021 61,84 62,40 59,75 60,05 -2,69% 4,29% 509.900
04/10/2021 62,25 62,26 60,80 61,71 -1,42% 2,34% 415.700
01/10/2021 62,28 62,98 60,41 62,60 +0,27% 4,13% 456.900
30/09/2021 61,38 63,55 61,02 62,43 +2,97% 4,12% 547.500
29/09/2021 60,37 61,89 60,22 60,63 -0,03% 2,77% 473.800
28/09/2021 64,91 64,91 60,45 60,65 -7,49% 6,87% 647.500
27/09/2021 65,44 65,84 63,91 65,56 +0,29% 2,95% 534.300
24/09/2021 63,96 65,56 63,41 65,37 +1,04% 3,36% 592.800
23/09/2021 62,69 64,83 61,89 64,70 +3,11% 4,69% 508.900
22/09/2021 62,47 63,12 61,89 62,75 +0,63% 1,96% 308.400
21/09/2021 62,61 63,94 62,13 62,36 -0,06% 2,89% 327.000
20/09/2021 63,58 64,55 61,97 62,40 -3,90% 4,06% 454.900
17/09/2021 64,24 65,01 62,61 64,93 +1,99% 3,74% 1.753.900
16/09/2021 63,43 63,85 62,29 63,66 +0,24% 2,47% 350.100